Immunopotentiator Aikejia improves the therapeutic efficacy of PD-1/PD-L1 immunosuppressive pathway in CT26.WT cancer cell

Tumors can escape immunosurveillance through immunocheckpoint such as the PD-1/PD-L1 pathway. Aikejia comes from Nocardia rubra cell-wall skeleton and can increase the number of inflammatory factors and immune cells. In this work, we showed that the levels of PD-L1 increase in CT26.WT xenograft afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chaoqun, Tang, Xiaoqiong, Li, Suhuan, Wang, Qingshui, Xie, Bifeng, Xu, Jing, Lin, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603415/
https://www.ncbi.nlm.nih.gov/pubmed/31293651
http://dx.doi.org/10.7150/jca.29672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603415/
https://www.ncbi.nlm.nih.gov/pubmed/31293651
http://dx.doi.org/10.7150/jca.29672

Ejemplares similares